非优势半球运动区胶质瘤切除:清醒或睡眠运动定位的多模态评分开发与验证
评分指导选择睡眠(高频刺激)或清醒(低频和高频刺激)运动定位,验证组术后运动-运用障碍率低(3%),切除程度高(中位97%,完全切除>70%)。
要点
- 术前运动缺损、既往治疗、肿瘤位于或邻近中央沟者倾向选择睡眠运动定位(高频刺激)。
- 肿瘤体积>30 cm3且累及运用网络者倾向选择清醒运动定位(低频和高频刺激及运用任务评估)。
- 按评分选择定位策略,术后运动-运用障碍率低(3%),切除程度高(中位97%)。
核心结论
- 涉及运动控制 eloquent 区的肿瘤广泛切除可行,应用合适的定位策略时术后运动-运用障碍发生率低。
- 睡眠(高频刺激)运动定位更适用于邻近或累及中央沟、术前有肌力缺损和/或既往治疗史的患者。
- 无运动缺损及既往治疗、肿瘤>30 cm3且累及运用网络者,清醒定位更佳。
研究设计与样本
- 前瞻性验证52例患者(35例清醒定位,17例睡眠定位,依据评分指示)。
主要发现
- 回顾性分析中,既往运动(肌力)缺损、既往治疗(手术/放疗)、肿瘤体积>30 cm3、肿瘤累及运用网络(MRI)被用于设计定位评分。
- 运动缺损、既往治疗及位于或邻近中央沟者倾向睡眠运动定位;大肿瘤体积和累及运用网络者倾向清醒运动定位。
- 前瞻性验证组术后运动-运用障碍率3%,切除程度中位97%,完全切除>70%。
关键数值与推荐
- 评分因素:既往运动(肌力)缺损、既往治疗(手术/放疗)、肿瘤体积>30 cm3、肿瘤累及运用网络(MRI)。
- 睡眠运动定位指征:运动缺损、既往治疗、位于或邻近中央沟。
- 清醒运动定位指征:肿瘤体积>30 cm3、累及运用网络。
- 验证组结果:术后运动-运用障碍率3%,切除程度中位97%,完全切除>70%。
临床怎么用
- 对非优势半球中央沟附近胶质瘤,可依据运动定位评分选择睡眠或清醒运动定位策略。
- 术前有肌力缺损、既往治疗史或病灶位于/邻近中央沟者,优先考虑睡眠(高频刺激)运动定位。
- 无运动缺损及既往治疗、肿瘤>30 cm3且累及运用网络者,优先考虑清醒定位(低频和高频刺激及运用任务评估)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Resection of glioma in the nondominant hemisphere involving the motor areas and pathways requires the use of brain-mapping techniques to spare essential sites subserving motor control. No clear indications are available for performing motor mapping under either awake or asleep conditions or for the best mapping paradigm (e.g., resting or active, high-frequency [HF] or low-frequency [LF] stimulation) that provides the best oncological and functional outcomes when tailored to the clinical context. This work aimed to identify clinical and imaging factors that influence surgical strategy (asleep motor mapping vs awake motor mapping) and that are associated with the best functional and oncological outcomes and to design a "motor mapping score" for guiding tumor resection in this area. METHODS: The authors evaluated a retrospective series of patients with nondominant-hemisphere glioma-located or infiltrating within 2 cm anteriorly or posteriorly to the central sulcus and affecting the primary motor cortex, its fibers, and/or the praxis network-who underwent operations with asleep (HF monopolar probe) or awake (LF and HF probes) motor mapping. Clinical and imaging variables were used to design a motor mapping score. A prospective series of patients was used to validate this motor mapping score. RESULTS: One hundred thirty-five patients were retrospectively analyzed: 69 underwent operations with asleep (HF stimulation) motor mapping, and 66 underwent awake (LF and HF stimulation and praxis task evaluation) motor mapping. Previous motor (strength) deficit, previous treatment (surgery/radiotherapy), tumor volume > 30 cm3, and tumor involvement of the praxis network (on MRI) were identified and used to design the mapping score. Motor deficit, previous treatment, and location within or close to the central sulcus favor use of asleep motor mapping; large tumor volume and involvement of the praxis network favor use of awake motor mapping. The motor mapping score was validated in a prospective series of 52 patients-35 underwent operations with awake motor mapping and 17 with asleep motor mapping on the basis of the score indications-who had a low rate of postoperative motor-praxis deficit (3%) and a high extent of resection (median 97%; complete resection in > 70% of patients). CONCLUSIONS: Extensive resection of tumor involving the eloquent areas for motor control is feasible, and when an appropriate mapping strategy is applied, the incidence of postoperative motor-praxis deficit is low. Asleep (HF stimulation) motor mapping is preferable for lesions close to or involving the central sulcus and/or in patients with preoperative strength deficit and/or history of previous treatment. When a patient has no motor deficit or previous treatment and has a lesion (> 30 cm3) involving the praxis network, awake mapping is preferable.
引用
- Rossi M, Puglisi G, Conti Nibali M, et al. Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy. J Neurosurg. 2021. PMID: 34144525. doi:10.3171/2020.11.JNS202715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。